Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bausch Health Companies Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BHC
New York
2830
www.bauschhealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bausch Health Companies Inc.
Will Bausch (BHC) Gain on Rising Earnings Estimates?
- Nov 10th, 2025 10:20 am
Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease
- Nov 5th, 2025 6:00 am
Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More
- Oct 31st, 2025 9:11 am
Bausch Health (BHC): Profitability Milestone Reinforces Value Narrative Despite One-Time $159M Loss
- Oct 31st, 2025 6:18 am
Bausch Health (BHC) Q3 2025 Earnings Transcript
- Oct 30th, 2025 3:41 pm
Bausch Health Companies Inc (BHC) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
- Oct 30th, 2025 2:08 pm
TSX up 120 Points at Midday With Healthcare The Best Performer
- Oct 30th, 2025 10:12 am
BHC Stock Up on Q3 Earnings Beat, Salix and Solta Drive Sales
- Oct 30th, 2025 8:28 am
Bausch: Q3 Earnings Snapshot
- Oct 30th, 2025 3:07 am
Bausch Health Announces Third Quarter 2025 Results
- Oct 29th, 2025 2:05 pm
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
- Oct 27th, 2025 2:06 pm
Bausch Health (BHC) Expected to Beat Earnings Estimates: Should You Buy?
- Oct 22nd, 2025 8:00 am
Assessing Bausch Health Companies (NYSE:BHC) Valuation After Recent Share Price Volatility
- Oct 12th, 2025 4:04 pm
Bausch Health Announces Results of Special Meeting of Shareholders
- Oct 9th, 2025 5:00 am
George Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab FarmacĂȘutica licensing agreement in Brazil
- Oct 2nd, 2025 5:00 am
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
- Sep 30th, 2025 6:00 am
Bausch Health to Announce Third Quarter 2025 Results on October 29
- Sep 30th, 2025 5:00 am
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
- Sep 29th, 2025 6:00 am
TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors
- Sep 24th, 2025 6:00 am
How the FDA Is Taking Aim at the Surreal World of TV Drug Ads
- Sep 21st, 2025 3:30 am
Scroll